You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

refractory/relapsed acute myelogenous leukemia

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Acute Lymphocytic (ALL), Leukemia, Acute Myelogenous (AML), MDS Trial in Guangzhou (Chimeric antigen receptor T cells,

Recruiting
  • Leukemia, Acute Lymphocytic (ALL)
  • +2 more
  • Chimeric antigen receptor T cells
  • peptide specific dendritic cell
  • Guangzhou, Guangdong, China
    Zhujiang Hospital, Southern Medical University
Aug 1, 2021

Refractory Acute Myelogenous Leukemia, Relapsed Acute Myelogenous Leukemia Trial in Minneapolis (FATE-NK100)

Completed
  • Refractory Acute Myelogenous Leukemia
  • Relapsed Acute Myelogenous Leukemia
  • FATE-NK100
  • Minneapolis, Minnesota
    University of Minnesota, Masonic Cancer Center
Mar 10, 2021

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blasts 5 Percent or More of Bone Marrow Nucleated Cells,

Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +10 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 17, 2021

Acute Myelogenous Leukemia, MDS, Mixed Phenotype Acute Leukemia Trial (Fludarabine, Cytarabine, Uproleselan)

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +2 more
  • (no location specified)
Mar 3, 2022

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti Tim-3/CD123 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Nov 4, 2023

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • Acute Lymphoblastic Leukemia With Failed Remission
  • São Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
Sep 12, 2023

Acute Myelogenous Leukemia Trial in Sacramento (Bortezomib, Doxil)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • Sacramento, California
    University of California Comprehensive Cancer Center
Feb 4, 2021

Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • CD123 targeted CAR-NK cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Aug 28, 2023

Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

Recruiting
  • Acute Myeloid Leukemia
  • Beijing, Beijing, China
    Peking University People's Hospital
Jun 23, 2023

Relapsed/Refractory Acute Myeloid Leukemia Trial in Hangzhou (B7-H3 target, CAR gene modified gdT cell injection)

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • B7-H3 target, CAR gene modified gdT cell injection
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital， Zhejiang University School of Med
Feb 15, 2023

Acute Myelogenous Leukemia Trial in Canada, United States (TAK-659)

Terminated
Has Results
  • Acute Myelogenous Leukemia
  • Birmingham, Alabama
  • +16 more
Apr 14, 2021

B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • HY004
  • +2 more
  • (no location specified)
Aug 18, 2023

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • (no location specified)
Nov 9, 2023

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

    Recruiting
    • Relapsed or Refractory Acute Myeloid Leukemia
    • Taiyuan, Shanxi, China
      Tao Wang
    Feb 9, 2023

    B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • QH103 Cell Injection
    • +2 more
    • Hefei, Anhui, China
      Anhui Provincial Hospital
    Sep 21, 2023

    AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

    Not yet recruiting
    • AML
    • +11 more
    • (no location specified)
    Aug 14, 2023

    PET-CT Imaging in Relapsed/Refractory Acute Leukemias

    Not yet recruiting
    • B Cell
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 4, 2023

      Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

      Recruiting
      • Neoplasms
      • +2 more
      • RD13-02 cell infusion
      • Xuzhou, Jiangsu, China
        Affiliated hospital of Xuzhou medical college
      Jun 7, 2023

      B-cell Acute Lymphoblastic Leukemia Trial (CD19-CAR_Lenti_ALLO)

      Not yet recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • (no location specified)
      Oct 10, 2023

      Relapsed/Refractory Acute Myeloid Leukemia Trial in Hefei (gdT cell injection targeting B7-H3 chimeric antigen receptor)

      Recruiting
      • Relapsed/Refractory Acute Myeloid Leukemia
      • gdT cell injection targeting B7-H3 chimeric antigen receptor
      • Hefei, Anhui, China
        PersonGen Anke Cellular Therapeutice Co., Ltd.
      Jan 31, 2023

      Relapsed/Refractory AML Trial in Suzhou (Selinexor, Homoharringtonine, Cytarabine)

      Not yet recruiting
      • Relapsed/Refractory AML
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Mar 28, 2023

      T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

      Not yet recruiting
      • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
      • CD7-CART01
      • (no location specified)
      Sep 26, 2023

      Acute Myeloid Leukemia (Relapsed/Refractory) Trial in Suzhou (Selinexor, Chidamide)

      Recruiting
      • Acute Myeloid Leukemia (Relapsed/Refractory)
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Jul 16, 2023

      Acute Myeloid Leukemia Trial in Minneapolis (ALT-803)

      Completed
      Has Results
      • Acute Myeloid Leukemia
      • ALT-803
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      Oct 30, 2020